Related news and resources

Report 6 Jun 2024

The development and manufacture of vaccines to protect global health (IFPMA & DCVMN)

IFPMA has partnered with DCVMN to share our industry’s expertise in vaccine development and manufacturing. This presentation illustrates the key stages and timeline to bring vaccines to the market.

Read more
Statement 1 Mar 2024

IFPMA Statement at the closing of the WTO Ministerial Conference in Abu Dhabi

On 1 March, at the end of the 13th WTO Ministerial Conference, IFPMA issued a statement.

Read more
Infographic 23 Feb 2024

February 2024: Impact of a waiver of intellectual property rights for COVID-19 therapeutics

As discussions on an extension of a waiver of intellectual property (IP) rights on COVID-19 therapeutics continue, latest evidence and data published today explains what the adverse impact of a waiver may be on the entire innovation ecosystem and the consequences it may have on industry’s ability to fight future pandemics.

Read more
Top